Royalty Pharma Investments 2019 ICAV - Insider Trading & Ownership

Entity
Individual
Location
C/O Rp Management, Llc, 100 E. 59 Th St., 33 Rd Floor, New York, NY
Summary
The estimated net worth of Royalty Pharma Investments 2019 ICAV is at least $32M dollars as of February 9, 2022. Royalty Pharma Investments 2019 ICAV is the Director, 10%+ Owner of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $32M.
All Insider Reports
All Insider Reports

Ownership of Royalty Pharma Investments 2019 ICAV

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EPZM Epizyme, Inc. Director, 10%+ Owner $32M Jan 31, 2022

There are no insider transactions reported by Royalty Pharma Investments 2019 ICAV